STOCK TITAN

Alpha Cognition (NASDAQ: ACOG) director granted RSUs, options in filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Alpha Cognition Inc. director Leonard Powell Mertz reported new equity awards. On 01/14/2026, he acquired 7,241 common shares as restricted stock units at $0, which will vest one year from the grant date. On the same date, he was granted 8,437 common share options with an exercise price of $6.56; these options also vest one year from the grant date and expire on 01/14/2036.

After these awards, he directly beneficially owned 145,736 common shares and 8,437 common share options. He also indirectly beneficially owned 121,503 common shares through The Len Mertz Trust.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MERTZ LEONARD POWELL

(Last) (First) (Middle)
C/O ALPHA COGNITION INC.
1452 HUGHES RD., SUITE 200

(Street)
GRAPEVINE TX 76051

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Alpha Cognition Inc. [ ACOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/14/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 01/14/2026 A 7,241(1) A $0 145,736 D
Common Shares 121,503 I by The Len Mertz Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Share Options $6.56 01/14/2026 A 8,437 (2) 01/14/2036 Common Shares 8,437 $0 8,437 D
Explanation of Responses:
1. Restricted stock units that vest one year from date of grant.
2. The options will vest one year from date of grant.
/s/ Leonard Powell Mertz 01/16/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Alpha Cognition (ACOG) report in this Form 4?

The filing shows director Leonard Powell Mertz received new equity awards on 01/14/2026, including restricted stock units and stock options in Alpha Cognition Inc. common shares.

How many Alpha Cognition (ACOG) shares did the director acquire, and at what price?

He acquired 7,241 common shares in the form of restricted stock units at a price of $0 per share, as part of an equity award.

What stock options were granted to the Alpha Cognition (ACOG) director?

He was granted 8,437 common share options with an exercise price of $6.56 per share, expiring on 01/14/2036.

When do the new Alpha Cognition (ACOG) equity awards vest?

The filing states that the restricted stock units vest one year from the date of grant, and the options will vest one year from the date of grant, which is 01/14/2026.

How many Alpha Cognition (ACOG) shares does the director own after these transactions?

Following the reported transactions, he directly beneficially owned 145,736 common shares and 8,437 common share options, and indirectly beneficially owned 121,503 common shares through The Len Mertz Trust.

What is the director’s relationship to Alpha Cognition (ACOG)?

The reporting person, Leonard Powell Mertz, is identified in the filing as a director of Alpha Cognition Inc. and is not marked as a 10% owner or officer.
Alpha Cognition

NASDAQ:ACOG

ACOG Rankings

ACOG Latest News

ACOG Latest SEC Filings

ACOG Stock Data

126.54M
19.65M
12.97%
35.39%
0.5%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
Canada
VANCOUVER